Dihydrodaidzein diacetate → HCID 67135424, 화합물

HRID 603293노트

반응식

HRID 603293 반응식
[C:1]([O:4][C:5]1[CH:25]=[CH:24][C:8]([CH:9]2[C:18](=[O:19])[C:17]3[C:12](=[CH:13][C:14]([O:20][C:21](=[O:23])[CH3:22])=[CH:15][CH:16]=3)[O:11][CH2:10]2)=[CH:7][CH:6]=1)(=[O:3])[CH3:2]>C(OCC)(=O)C.[Pt](=O)=O>[C:1]([O:4][C:5]1[CH:25]=[CH:24][C:8]([C@H:9]2[C@@H:18]([OH:19])[C:17]3[C:12](=[CH:13][C:14]([O:20][C:21](=[O:23])[CH3:22])=[CH:15][CH:16]=3)[O:11][CH2:10]2)=[CH:7][CH:6]=1)(=[O:3])[CH3:2]

참가 물질

4

반응물 1

HCID 9862762Dihydrodaidzein diacetate

생성물 1

HCID 67135424HCID 67135424, 화합물

시약·촉매·용매 2

HCID 345198Adams' catalyst촉매HCID 8857Ethyl Acetate용매

실험 절차

Platinum(IV)oxide (Adam's catalyst) (0.05 g) was added to a solution of 4′,7-diacetoxyisoflavanone (0.25 g, 0.7 mmol) in ethyl acetate (40 ml) and the mixture was stirred at room temperature under a hydrogen atmosphere for 55 h. The catalyst was removed by filtration through Celite and the filtrate was evaporated in vacuo to yield predominantly the cis-4′,7-diacetoxyisoflavan-4-ol.

후처리

  1. customThe catalyst was removed by filtration through Celite
  2. customthe filtrate was evaporated in vacuo

출처 및 근거

ORD 기록
ord-cb39ddf28adc4c40887f0bcc98929989
출처 데이터셋
uspto-grants-2011_03
특허 번호
US07906660B2

반응 노트

불러오는 중…